article thumbnail

Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine

Physician's Weekly

MONDAY, June 23, 2025 (HealthDay News) — The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meniere disease (MD) and vestibular migraine (VM), according to a study published online May 13 in Frontiers in Neurology.

Diagnosis 104
article thumbnail

Mixed Autoimmune Hemolytic Anemia Clinical Profile and Treatment

Physician's Weekly

The following is a summary of “Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes,” published in the May 2025 issue of American Journal of Hematology by Jacobs et al. The median age of the participants was 45 years, with a marked female predominance of 2.25:1.

Clinic 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI Model Can Aid Physicians in Skin Cancer Diagnoses

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June 6 in Nature Medicine. percent across 128 skin conditions on clinical photographs. PanDerm outperformed clinicians by 10.2

article thumbnail

Dual-Energy CT Advances Arthritis Imaging

Physician's Weekly

Contrast-enhanced dual-energy CT improves diagnosis and guided management of suspected inflammatory arthritis of the hand. The CE-DECT findings matched the final diagnosis in 119 patients (87.5%). Diagnosis changed after CE-DECT in 67 patients (49.2%). Rheumatologists rated CE-DECT’s diagnostic utility at a mean of 8.5 (SD

article thumbnail

Passive Digital Marker Can Identify Childhood Asthma Risk

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — It is feasible to use electronic health record (EHR) data in the Pediatric Asthma Risk Score (PARS) to accurately predict childhood asthma risk, according to a study published in the June issue of eClinicalMedicine. percent) had a confirmed asthma diagnosis after age 4 years.

Asthma 52
article thumbnail

Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa

Physician's Weekly

Eligible patients were aged 6 years or older, with a confirmed clinical and genetic diagnosis of RDEB, and at least two chronic wounds. Abstract/Full Text (subscription or payment may be required) Editorial (subscription or payment may be required) Copyright © 2025 HealthDay. All rights reserved.

article thumbnail

Molecular Analysis Improves FH Prognosis & Risk Stratification

Physician's Weekly

Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy. The researchers published their findings before the National Lipid Association’s 2025 meeting, though not as part of it.